×

Get the Prostate Cancer Patient Guide as a digital download or free mailed copy.

Click here.

02-14_BreakingNews_FeaturedImg745x510.jpg

FDA Approves Apalutamide (Erleada); the first treatment for non-metastatic castration-resistant prostate cancer

February 14, 2018 – Today the U.S. Food and Drug Administration (FDA) approved apalutamide (Erleada, also previously called ARN-509) for the treatment of non-metastatic castration-resistant prostate cancer (non-metastatic CRPC).  This...Read More

Blood Profiling Atlas in Cancer Consortium (BloodPAC) Announces Milestone in Accelerating Development of Liquid Biopsy for Cancer: Initial Release of Open Data

Blood Profiling Atlas in Cancer Consortium (BloodPAC) Announces Milestone in Accelerating Development of Liquid Biopsy for Cancer: Initial Release of Open Data

CHICAGO – Exactly one year after its establishment as an independent non-profit, The Blood Profiling Atlas in Cancer Consortium (BloodPAC) announced the public release and accessibility of an initial dataset....Read More

Hussain-Small_ResearchStoryFeatImg_745x510

Two new treatments have been found for prostate cancer patients who previously had no effective treatment options

Over the course of prostate cancer progression, there can come a time during which the cancer is progressing, but there are no treatments known to improve survival.  One of these...Read More

FDA approves Abiraterone + Prednisone for Earlier Treatment of Metastatic Prostate Cancer

FDA approves Abiraterone + Prednisone for Earlier Treatment of Metastatic Prostate Cancer

Back in June, we told you about the early results of the LATITUDE clinical trial, presented at the 2017 ASCO conference.   The study indicated that giving abiraterone in combination with...Read More

Statins and Prostate Cancer: The Search for the Magic Bullet

Statins and Prostate Cancer: The Search for the Magic Bullet

Do statins lower your risk of getting aggressive prostate cancer?  Well, they may. Study after study hints at a tantalizing connection between taking these cholesterol-lowering drugs and protection from getting...Read More

TRUE Love Contest

The Prostate Cancer Foundation Honors Family And Caregivers During February With The True Love Contest

SANTA MONICA, CA, January 31, 2018 – Starting February 1st, the Prostate Cancer Foundation (PCF) will kick-off a month-long TRUE Love contest that honors family and caregivers for their tireless...Read More

2017_PCFChallengeAwdsAnnounce_FeaturedImg745x510

The Prostate Cancer Foundation Awards Unprecedented Number of New Research Grants

SANTA MONICA, Calif., January 23, 2018 – Celebrating its 25th year as the global leader in driving cutting-edge research leading to treatments and cures for prostate cancer, the Prostate Cancer...Read More

Cleveland Clinic researchers find new gene variant linked to deadly prostate cancer

Cleveland Clinic researchers find new gene variant linked to deadly prostate cancer

Jan. 17 2018, Cleveland: Cleveland Clinic researchers have confirmed for the first time a mechanistic link between the gene HSD17B4 and deadly, treatment-resistant prostate cancer. The research, led by Nima...Read More

RFS-Hi-Res-Photo_600x

$2.5 Million Gift from Robert Frederick Smith to the Prostate Cancer Foundation is the Largest Donation Ever Dedicated to Advancing Prostate Cancer Research in African-American Men

SANTA MONICA, CA Jan. 14, 2018 – Helping to advance revolutionary research in prostate cancer, Robert F. Smith, Founder, Chairman and CEO of Vista Equity Partners, has donated $2.5 million...Read More

DanFogelberg_Hero

Star-Studded Album Honoring Dan Fogelberg Will Benefit the Prostate Cancer Foundation

LOS ANGELES, November 21, 2017 - The highly-anticipated album, A Tribute to Dan Fogelberg, is now available on CD, digital and streaming platforms. Released worldwide through BMG, sales will benefit the Prostate...Read More